About
Joshua Cohen is Co-Founder and Co-CEO of Amylyx Pharmaceuticals (NASDAQ: AMLX), a company developing therapies for neurodegenerative and endocrine diseases including post-bariatric hypoglycemia, congenital hyperinsulinism, Wolfram syndrome, and amyotrophic lateral sclerosis. The company's clinical assets include avexitide, which is in Phase 3 development.
Founder at Amylyx
Intro paths
→
In turn, Joshua can intro founders to Amylyx's investors below.
Amylyx's investors · 2
Experience
- Amylyx PharmaceuticalsCo-Founder and Co-CEO at Amylyx Pharmaceuticalscurrent2013 — present
- NISTEngineering Researcher2012Gaithersburg, MD
Skills & more
Biomedical Engineering12Research11Biomaterials4Microfluidics3Tissue Engineering3Statistics7COMSOL4Biotechnology4Alzheimer's disease5Data Analysis4Social Media3Public Speaking5
+11 more
MatlabStataLabviewMathematicaPowerPointLabVIEWMicrosoft WordMicrosoft ExcelMicrosoft OfficePythonPharmaceutical IndustryFrom Joshua's professional profile.
Frequently asked questions
- Who is Joshua Cohen?
- Joshua Cohen is Co-Founder and Co-CEO of Amylyx Pharmaceuticals (NASDAQ: AMLX), a company developing therapies for neurodegenerative and endocrine diseases including post-bariatric hypoglycemia, congenital hyperinsulinism, Wolfram syndrome, and amyotrophic lateral sclerosis. The company's clinical assets include avexitide, which is in Phase 3 development.
- Where does Joshua Cohen work?
- Joshua Cohen is Founder of Amylyx.
- What companies did Joshua Cohen found?
- Joshua Cohen founded Amylyx.
- Where did Joshua Cohen go to school?
- Joshua Cohen studied at Brown University (Bachelors, Biomedical Engineering); Milton Academy (High School).
Same school
Shared employers
Also worked at Amylyx Pharmaceuticals1
Also worked at NIST16
Aaron VanDevenderAdvisor at Long Journey VenturesKevin SimmonsGeneral Partner at LoftyInc CapitalKathy PhamInvestor at Blue Tulip VenturesOla SchröderPartner at Nordia Management OyGali BalerPartner at CU Healthcare Innovation FundAshok ShrivastavaSVP, Chief Data Officer at Synapse Partners
+ 10 more













